Study: Centuries-old mercury pollution threatens Arctic wildlife
June 12 (UPI) -- Mercury concentrations in Arctic wildlife are on the rise despite reductions in mercury release, according to a new study published Thursday.
Researchers from Aarhus University and the University of Copenhagen found that ocean currents may be transporting centuries-old mercury pollution to the Arctic, the study published in the journal Nature Communications said.
"We've monitored mercury in Arctic animals for over 40 years. Despite declining global emissions since the 1970s, we see no corresponding decrease in Arctic concentrations -- on the contrary," said Professor Rune Dietz from Aarhus University said in a statement.
Mercury from coal combustion and gold mining can remain in the air for about a year but when it enters the ocean, it can stay for 300 years.
Researchers have looked at more than 700 environmental samples from animals across Greenland over the past 40 years which has led them to identify regional differences that go alongside current patterns.
"These isotope signatures act like fingerprints, revealing the sources and transport pathways of mercury," Senior Researcher Jens Sondergaard from Aarhus University explained.
Mercury disrupts the normal function of nervous systems in polar bears and toothed whales. The concentrations are higher by 20-30 times before industrialization. It creates serious health risks to native marine mammals.
"Transport of mercury from major sources like China to Greenland via ocean currents can take up to 150 years," said Rune Dietz. "This helps explain the lack of decline in Arctic mercury levels."
The "GreenPath" project team is continuing its work on the study of mercury pollution across the Arctic.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
10 hours ago
- UPI
Red, white and blue on the Red Planet
July 3 (UPI) -- On the eve of the 249th anniversary of American independence, NASA on Tuesday showcased a patriotic image of Old Glory as seen from hundreds of millions of miles away. A plaque bearing the United States flag is on an aluminum plate at the base of the mast, or "head," of NASA's Perseverance rover on the Red Planet. An image of the flag was taken on June 28 by the WATSON (Wide Angle Topographic Sensor for Operations and eNgineering) camera on the end of the rover's robotic arm. On Tuesday, NASA published an image of the flag on the rover, as seen during its 1,548th day of its mission. WATSON was built by Malin Space Science Systems in San Diego and is operated jointly by Malin Space Science Systems and NASA's Jet Propulsion Laboratory in Southern California. JPL, managed by Caltech, built and manages operations of Perseverance. The first U.S. flag planted somewhere besides Earth was the one planted on the moon by Buzz Aldrin in 1969. It signaled the United States had won the so-called Space Race with the Soviet Union.
Miami Herald
13 hours ago
- Miami Herald
Science seek to tap amazing healing powers of the mouth's interior
ST. PAUL, Minn., July 2 (UPI) -- The cellular action that enables the mouth's interior lining to heal quicky and without scarring has always been a mystery but a new study suggests it may be linked to a specific "signaling pathway." That new knowledge is raising hopes the mouth lining's healing powers could be applied to other skin wounds, which take far longer to heal and often leave permanent, unsightly scars, according to a preclinical study published Wednesday by Cedars-Sinai Medical Center and University of California-San Francisco researchers. The study on mice provides evidence that the "Gas6/AXL" protein/enzyme signaling pathway is likely responsible for the mouth's amazing ability to heal itself completely from even deep bite wounds within a matter of days with no leftover scarring, the authors wrote in the journal Science Translational Medicine. Known as the oral mucosa, the mouth's interior lining heals fast and cleanly, even though it is continuously exposed to different types of microbes, abrasion from foods, motion and tension. This unique regenerative capacity is made possible by specialized gene programs activated during injury, but just how those mechanisms work has been unknown. In the study reported Wednesday, a research team led by Dr. Ophir Klein, executive vice dean of Children's Health at Cedars-Sinai and executive director of Cedars-Sinai Guerin Children's in Los Angeles, found that by manipulating levels of the AXL enzyme they could affect how wounds healed. For instance, if they inhibited AXL in mice, the healing of oral mucosa wounds worsened, making them more like skin wounds. Conversely, when they stimulated AXL in facial skin wounds, they healed more efficiently and with reduced scarring, much like the oral mucosa. Boosting the levels of AXL suppresses the expression of another protein called Focal Adhesion Kinase, or FAK, which plays a significant role in scar formation during wound healing. Should future research validate the benefits for humans, the new knowledge could aid in developing new therapies to heal skin wounds with reduced scarring, Klein said. "We are actively thinking about harnessing AXL-driven repair in both the mouth and the skin, and perhaps in other tissues as well," he told UPI in emailed comments. "One application that comes to mind is to improve healing and reduce scarring in the skin for burn victims or those with other cutaneous disorders. "Another is that there are a number of diseases of the mouth, many of them autoimmune, in which severe oral ulcers form and heal poorly or not at all. These are different from canker sores, also known as aphthous ulcers, which many people get and which typically heal on their own; the more severe ulcers are difficult to treat and cause very significant illnesses, and we currently do not have good therapies for them." A related direction for research could focus on "obtaining a deeper understanding of the effects of AXL signaling on scarring and regeneration at a molecular level, in terms of other components of the signaling pathways," Klein added. "It will also be interesting to explore the role of this pathway in other tissues and organs, and in the context of distinct injuries and perturbations --for example, physical cuts vs heat burns vs irradiation versus chemical insults." Meanwhile, a pair of recent animal studies led by the University of Arizona in Tucson similarly have shown that the use of FAK inhibitors can make skin grafts look more like healthy skin and produce less scarring, raising hopes for a potential new treatment for survivors of blast wounds, burns and other major injuries. Kellen Chen, an assistant research professor in the university's Department of Surgery and lead author of those papers, said the current Cedars-Sinai study appears to add to a mounting list of evidence that "FAK acts as a central mediator of scarring in the oral mucosa gives additional credence to the importance of this factor." Chen was not involved with the new study. "A better understanding of how the oral mucosa heals without scarring through the FAK pathway will allow us to better develop therapies to target FAK for healing in the future," he told UPI. Chen said his team has the funding to pursue Food and Drug Administration approval for a FAK inhibitor, or FAKI, hydrogel therapy and expects to conduct human trials soon. The growing evidence that wound healing can be accelerated at the cellular level "could have strong clinical implications for the treatment of severe injuries for humans and animals, especially because there are zero FDA-approved treatments that reduce scar formation," he added. "Patients with severe injuries or burns can suffer a lifetime of pain and disfigurement from scarring. The potential to heal burn injuries with regeneration, rather than scarring, would dramatically change the lives of these patients." Copyright 2025 UPI News Corporation. All Rights Reserved.
Miami Herald
13 hours ago
- Miami Herald
Study: Statins could prevent tens of thousands of heart attacks, strokes
July 2 (UPI) -- Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking cholesterol-lowering drugs, a new study says. More than 39,000 deaths, nearly 100,000 non-fatal heart attacks and up to 65,000 strokes in the U.S. could be prevented if people eligible for statins and other cholesterol-lowering drugs were taking them, researchers reported Monday in the Journal of General Internal Medicine. Nearly half of Americans (47%) who have never had a heart attack or stroke are eligible to take statins under U.S. guidelines, researchers found. But fewer than a quarter (23%) of them have been prescribed the life-saving drugs, results show. A substantial number of heart attack or stroke survivors also aren't taking the drugs, even though all are eligible for them under U.S. guidelines, researchers said. 'These results add to a growing body of evidence that there are important shortcomings in the quality of care for common and costly chronic diseases such as high cholesterol, and that addressing those shortcomings would yield major public health benefits,' lead researcher Dr. Caleb Alexander, a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health, said in a news release. For the study, researchers analyzed data from nearly 5,000 U.S. adults between 40 and 75 years of age who took part in an annual U.S. Centers for Disease Control and Prevention health survey between 2013 and 2020. The survey included data on the people's 'bad' LDL cholesterol levels and their overall heart health risk profile. Researchers used that info to determine whether they'd be eligible to take cholesterol-lowering drugs under current guidelines. Even people who had suffered a prior heart attack and stroke -- and thus are at higher risk for a follow-up event -- aren't always prescribed statins, researchers found. Only about two-thirds (68%) are taking statins, even though all are eligible for the drugs under the guidelines, results show. Along with warding off heart attacks and strokes, properly prescribed statins also could prevent every year nearly 88,000 heart bypass surgeries and procedures to reopen blocked or clogged arteries, researchers estimated. If everyone eligible for statins took them, researchers estimate that average LDL cholesterol levels would drop sharply and the risk of heart attack or stroke would fall by up to 27%. Preventing heart attacks and strokes through cholesterol-lowering drugs also could save more than $30 billion in annual medical costs for the U.S., researchers estimate. 'Several factors account for the gaps that we document,' Alexander said. 'They include differences in clinician training, patient preferences, barriers to accessing care, financial incentives that don't always support best practices, and the difficulty of putting clinical guidelines into practice in busy, real-world settings.' Better patient education and improved screening methods could make sure the right people are taking the statins they need, researchers said. 'High cholesterol is an important chronic health condition that silently claims far too many lives -there are millions of people walking around with this condition that don't even know they have it, and then when it is recognized it too often goes undertreated,' senior author Dr. Seth Martin, a professor of cardiology at the Johns Hopkins University School of Medicine, said in a news release. 'Evidence-based action is critical to close the gap and prevent devastating cardiovascular events,' he said. More information Harvard Medical School has more on statins. Copyright © 2025 HealthDay. All rights reserved. Copyright 2025 UPI News Corporation. All Rights Reserved.
